Elisa Dan
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients.
Journal: Bone marrow transplantation
Published: April 22, 2025
Epigenetic age acceleration in hematopoietic stem cell transplantation.
Journal: Haematologica
Published: March 20, 2024
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.
Journal: Haematologica
Published: February 27, 2024
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.
Journal: The Journal of clinical investigation
Published: June 16, 2023
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation.
Journal: Current opinion in hematology
Published: December 20, 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
Journal: Frontiers in oncology
Published: October 10, 2022
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients.
Journal: Frontiers in immunology
Published: September 30, 2022
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
Journal: Frontiers in immunology
Published: July 15, 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.
Journal: Frontiers in oncology
Published: March 21, 2022
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Journal: Frontiers in immunology
Published: October 29, 2021
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
Journal: Bone marrow transplantation
Published: February 10, 2021
Last Updated: 09/26/2026